IGF1 and obesity due to melanocortin 4 receptor deficiency: Obesity has been attributed to 15–20% of cancer-related deaths where obese individuals often present with higher levels of IGF-1 which has been identified as a potential mechanism associating obesity with increased cancer risk and disease progression [47,48,49].